Sign in

CIK 0001730430 · Large accelerated filer

Kiniksa Pharmaceuticals International, plc

Sign in to watch
Ticker
KNSA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
981795578
Phone
7814319100
Business address
105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
Former names
Kiniksa Pharmaceuticals, Ltd.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$78,588,440
in 8 filings, $78.6M under 10b5-1 plans

Net −$78,588,440. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Patel Sanj K −$51.7M CHAIRMAN & CEO sold 42% of stake
  2. Moat Ross −$9.6M CHIEF OPERATING OFFICER sold 91% of stake
  3. Paolini John F. −$8.9M CHIEF MEDICAL OFFICER sold 58% of stake
  4. Megna Michael R −$4.9M CHIEF ACCOUNTING OFFICER sold 80% of stake
  5. Ragosa Mark −$3.4M CHIEF FINANCIAL OFFICER sold 64% of stake
Date Insider Transaction Shares Price Value Owned after
2018-05-29 Mahoney Stephen F. President & COO Conversion +6,392 79,589
2018-05-29 Mahoney Stephen F. President & COO Conversion · Series A Preferred Shares −107,050 0
2018-05-29 Mahoney Stephen F. President & COO Conversion · Series C Preferred Shares −6,392 0
2018-05-29 Mahoney Stephen F. President & COO Conversion · Class B Common Shares +107,050 656,027
2018-05-29 Heberlig Chris Exec VP & CFO Conversion +6,392 42,991
2018-05-29 Heberlig Chris Exec VP & CFO Conversion · Series A Preferred Shares −74,935 0
2018-05-29 Heberlig Chris Exec VP & CFO Conversion · Series C Preferred Shares −6,392 0
2018-05-29 Heberlig Chris Exec VP & CFO Conversion · Class B Common Shares +74,935 440,920
2018-02-09 BAKER BROS. ADVISORS LP Director Purchase · Series C Preferred +420,897 420,897
2018-02-09 BAKER BROS. ADVISORS LP Director Purchase · Series C Preferred +3,734,103 3,734,103
2018-02-09 Patel Sanj K Chairman & CEO Purchase · Series C Preferred Shares +63,922 $15.64 $1000K 63,922
2018-02-09 Beetham Thomas W. Chief Legal Officer Purchase · Series C Preferred Shares +6,392 $15.64 $100K 6,392
2018-02-09 BOESS CARSTEN 10% owner Purchase · Series C Preferred Shares +6,392 $15.64 $100K 6,392
2018-02-09 Mahoney Stephen F. President & COO Purchase · Series C Preferred Shares +6,392 $15.64 $100K 6,392
2018-02-09 Heberlig Chris Exec VP & CFO Purchase · Series C Preferred Shares +6,392 $15.64 $100K 6,392

Page 80 of 80 · 1,595 trades